InfuSystem Holdings INFU Derivative Instruments
Derivative Instruments at other companies
Other financials
Where this comes from
Reported directly by InfuSystem Holdings in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent.
The official record: InfuSystem Holdings’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about InfuSystem Holdings's derivative instruments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is InfuSystem Holdings's derivative instruments?
- InfuSystem Holdings (INFU) reported derivative instruments of $18K in Q1 2026.
- How has InfuSystem Holdings's derivative instruments changed year-over-year?
- InfuSystem Holdings's derivative instruments increased by 105.5% year-over-year, from -$329K to $18K.
- What is the long-term trend for InfuSystem Holdings's derivative instruments?
- Over 4 years (2021 to 2025), InfuSystem Holdings's derivative instruments has grown at a 19.9% compound annual growth rate (CAGR), from $355K to -$733K.
- What does derivative instruments mean?
- This metric represents the change in the fair value of derivative financial instruments designated as cash flow hedges that has not yet been realized through settlement. It reflects the unrealized gains or losses on hedging activities intended to mitigate exposure to interest rate or commodity price volatility. Monitoring this figure helps investors assess the effectiveness of the company's risk management strategies and potential future impacts on equity.